Related Experiment Video

Updated: Jul 21, 2025

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.4K

The Multiple Faces of the MRN Complex: Roles in Medulloblastoma and Beyond

Marialaura Petroni1,2, Veronica La Monica1, Francesca Fabretti1

  • 1Department of Molecular Medicine, University La Sapienza, 00161 Rome, Italy.

Cancers
|July 29, 2023
PubMed

Insights

The MRN complex, crucial for DNA repair, paradoxically acts as both a tumor suppressor and promoter in cancer. Its dual role highlights potential as a therapeutic target and prognostic marker.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Mutations in the MRN complex are linked to cancer, suggesting oncosuppressive roles.
  • MRN proteins are often overexpressed in tumors, counteracting DNA damage from therapy and oncogene activity.
  • MRN genes are essential for embryonic development, with constitutive knockout causing lethality.

Purpose of the Study:

  • To review the multifaceted roles of the MRN complex in cancer pathology.
  • To explore the paradoxical functions of MRN genes as oncosuppressive, oncopromoting, and essential.
  • To discuss the implications of MRN complex alterations for cancer prognosis and therapy.

Main Methods:

  • Literature review of MRN complex functions in cancer.
  • Analysis of gene-dosage-dependent effects of NBS1 in Medulloblastoma.
  • Discussion of experimental evidence on MRN complex roles.

Main Results:

  • MRN complex mutations are associated with cancer development.
  • MRN complex overexpression counteracts DNA double-strand breaks (DSBs) in tumors.
  • NBS1 exhibits gene-dosage-dependent effects in Medulloblastoma.

Conclusions:

  • The MRN complex plays complex, context-dependent roles in cancer, acting as both a suppressor and promoter.
  • Understanding these dual roles is critical for evaluating the MRN complex as a therapeutic target.
  • Further research is needed to determine the MRN complex's utility as a prognostic or predictive marker in cancer patients.
Keywords:
DDRMRN complexRSRhaploinsufficiencyp53synthetic lethalitytarget therapy

More Related Videos

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.2K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.7K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K